Own = 4) ,20 mm . = 20 mm 24 (55) 20 (45) 84 (65) 45 (35) 48 (58) 34 (41) 12 (38) 18 (56) 0.17 25 (48) 27 (52) 109 (63) 60 (35) 34 (52) 30 (46) 0.Nodal status (unknown = 30) neg pos NHG (unknown = 5) I

Own = 4) ,20 mm . = 20 mm 24 (55) 20 (45) 84 (65) 45 (35) 48 (58) 34 (41) 12 (38) 18 (56) 0.17 25 (48) 27 (52) 109 (63) 60 (35) 34 (52) 30 (46) 0.Nodal status (unknown = 30) neg pos NHG (unknown = 5) I II III ER Status (unknown = 7) Negative Positive 2 (5) 41 (93) 6 (5) 121 (93) 13 (16) 69 (83) 11 (34) 19 (59) ,0.001** 6 (12) 45 (87) 13 (8) 155 (90) 13 (20) 50 (77) 0.096 7 (16) 13 (30) 24 (55) 40 (31) 54 (42) 34 (26) 14 (17) 37 (45) 31 (37) 7 (22) 9 (28) 14 (43) 0.86 8 (15) 18 (35) 26 (50) 44 (26) 74 (43) 50 (29) 16 (25) 21 (32) 27 (42) 0.35 26 (59) 17 (39) 70 (54) 44 (34) 41 (49) 31 (37) 18 (56) 10 (31) 0.97 27 (52) 20 (38) 90 (52) 61 (35) 38 (58) 21 (32) 0.PgR Status (unknown = 54) Negative Positive Age (unknown = 4) ,50 years .50 years Ki-67 (unknown = 13) 0?0 11?5 .25 14 (32) 14 (32) 14 (32) 63 (48) 37 (28) 26 (20) 24 (29) 28 (34) 28 (34) 7 (22) 11 (34) 11 (34) 0.059 14 (27) 22 (42) 14 (27) 70 (41) 56 (33) 39 (23) 24 (37) 12 (18) 26 (40) 0.71 4 (9) 40 (91) 11 (8) 118 (91) 20 (24) 62 (75) 6 (19) 24 (75) 0.007** 10 (19) 42 (81) 19 (11) 150 (87) 12 (18) 52 (80) 0.94 13 (30) 19 (43) 28 (22) 77 (59) 27 (33) 42 (51) 19 (59) 10 (31) 0.002** 17 (33) 25 (48) 43 (25) 91 (53) 27 (42) 32 (49) 0.HER2 status (unknown = 90) 0 1 2 3 17 (39) 11 (25) 3 (7) 2 (5) 50 (38) 27 (21) 6 (5) 1 (1) 25 (30) 25 (30) 7 (8) 4 (5) 6 (19) 9 (28) 2 (6) 4 (13 0.007** 18 (35) 12 (23) 3 (6) 4 (8) 64 (37) 40 (23) 9 (5) 5 (3) 16 (25) 20 (31) 6 (9) 2 (3) 0.doi:10.1371/journal.pone.0070596.tProliferation Assay and Cell Cycle ExperimentsThe proliferation assays were performed using [methyl-3H]thymidine incorporation as previously described [30]. Briefly, cells were seeded in 96-well plates and cultivated for 48 or 72 h with 1315463 addition of Methyl-3H-thymidine during the last 8 h. Cells were harvested using a Tomtec harvester 96 (Tomtec, Hamden, CT, USA) and scintillation measured in a 1450 Microbeta liquid scintillation counter (PerkinElmer, Waltham, MA, USA). Proliferation was also evaluated with the WST-1 cell proliferation reagent (Roche), where cells were seeded and cultivated as above. The WST-1 substance is cleaved by mitochondrial 548-04-9 dehydrogenases with a rate corresponding to the number of viable cells in the culture. During the last 2 h, 10 ml of the WST-1 reagent was added to each well and absorbance of the cleaved product was measured in a spectrophotometer as A450 nm 690 nm. In the statistical analysis, 61 SD was used for both proliferations assays.In general, data shown is representative of three individual experiments. Furthermore, a two-tailed paired t-test (in Excel assuming non equal variance) was performed on all data, and significance defined as a p-value below 0.05. Cell cycle analysis was performed according to standard procedure, as described in detail previously [31].Results and DiscussionIn this study, we have explored the prognostic and functional properties of the RNA-binding protein T-STAR. Using IHC, TSTAR was found to be expressed in various fractions and intensities in the tumor cell nuclei while AKT inhibitor 2 site Cytoplasmic staining, when present, was generally observed in all cells with varying intensity. The fraction of positive nuclei was scored and samples divided into groups as follows, 0 = ,10 , 1 = 11?0 , 2 = 51?5 and 3 =T-STAR Protein Expression in Breast CancerFigure 2. Kaplan-Meier curves showing T-STAR expression correlated to survival. A) Nuclear T-STAR expression in all cases. B) Nuclear TSTAR expression in ER+ cases only. C) Cytoplasmic T-STAR expr.Own = 4) ,20 mm . = 20 mm 24 (55) 20 (45) 84 (65) 45 (35) 48 (58) 34 (41) 12 (38) 18 (56) 0.17 25 (48) 27 (52) 109 (63) 60 (35) 34 (52) 30 (46) 0.Nodal status (unknown = 30) neg pos NHG (unknown = 5) I II III ER Status (unknown = 7) Negative Positive 2 (5) 41 (93) 6 (5) 121 (93) 13 (16) 69 (83) 11 (34) 19 (59) ,0.001** 6 (12) 45 (87) 13 (8) 155 (90) 13 (20) 50 (77) 0.096 7 (16) 13 (30) 24 (55) 40 (31) 54 (42) 34 (26) 14 (17) 37 (45) 31 (37) 7 (22) 9 (28) 14 (43) 0.86 8 (15) 18 (35) 26 (50) 44 (26) 74 (43) 50 (29) 16 (25) 21 (32) 27 (42) 0.35 26 (59) 17 (39) 70 (54) 44 (34) 41 (49) 31 (37) 18 (56) 10 (31) 0.97 27 (52) 20 (38) 90 (52) 61 (35) 38 (58) 21 (32) 0.PgR Status (unknown = 54) Negative Positive Age (unknown = 4) ,50 years .50 years Ki-67 (unknown = 13) 0?0 11?5 .25 14 (32) 14 (32) 14 (32) 63 (48) 37 (28) 26 (20) 24 (29) 28 (34) 28 (34) 7 (22) 11 (34) 11 (34) 0.059 14 (27) 22 (42) 14 (27) 70 (41) 56 (33) 39 (23) 24 (37) 12 (18) 26 (40) 0.71 4 (9) 40 (91) 11 (8) 118 (91) 20 (24) 62 (75) 6 (19) 24 (75) 0.007** 10 (19) 42 (81) 19 (11) 150 (87) 12 (18) 52 (80) 0.94 13 (30) 19 (43) 28 (22) 77 (59) 27 (33) 42 (51) 19 (59) 10 (31) 0.002** 17 (33) 25 (48) 43 (25) 91 (53) 27 (42) 32 (49) 0.HER2 status (unknown = 90) 0 1 2 3 17 (39) 11 (25) 3 (7) 2 (5) 50 (38) 27 (21) 6 (5) 1 (1) 25 (30) 25 (30) 7 (8) 4 (5) 6 (19) 9 (28) 2 (6) 4 (13 0.007** 18 (35) 12 (23) 3 (6) 4 (8) 64 (37) 40 (23) 9 (5) 5 (3) 16 (25) 20 (31) 6 (9) 2 (3) 0.doi:10.1371/journal.pone.0070596.tProliferation Assay and Cell Cycle ExperimentsThe proliferation assays were performed using [methyl-3H]thymidine incorporation as previously described [30]. Briefly, cells were seeded in 96-well plates and cultivated for 48 or 72 h with 1315463 addition of Methyl-3H-thymidine during the last 8 h. Cells were harvested using a Tomtec harvester 96 (Tomtec, Hamden, CT, USA) and scintillation measured in a 1450 Microbeta liquid scintillation counter (PerkinElmer, Waltham, MA, USA). Proliferation was also evaluated with the WST-1 cell proliferation reagent (Roche), where cells were seeded and cultivated as above. The WST-1 substance is cleaved by mitochondrial dehydrogenases with a rate corresponding to the number of viable cells in the culture. During the last 2 h, 10 ml of the WST-1 reagent was added to each well and absorbance of the cleaved product was measured in a spectrophotometer as A450 nm 690 nm. In the statistical analysis, 61 SD was used for both proliferations assays.In general, data shown is representative of three individual experiments. Furthermore, a two-tailed paired t-test (in Excel assuming non equal variance) was performed on all data, and significance defined as a p-value below 0.05. Cell cycle analysis was performed according to standard procedure, as described in detail previously [31].Results and DiscussionIn this study, we have explored the prognostic and functional properties of the RNA-binding protein T-STAR. Using IHC, TSTAR was found to be expressed in various fractions and intensities in the tumor cell nuclei while cytoplasmic staining, when present, was generally observed in all cells with varying intensity. The fraction of positive nuclei was scored and samples divided into groups as follows, 0 = ,10 , 1 = 11?0 , 2 = 51?5 and 3 =T-STAR Protein Expression in Breast CancerFigure 2. Kaplan-Meier curves showing T-STAR expression correlated to survival. A) Nuclear T-STAR expression in all cases. B) Nuclear TSTAR expression in ER+ cases only. C) Cytoplasmic T-STAR expr.